Aurinia Pharmaceuticals (AUPH) Shareholder's Equity (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.36% |
| Dec 31, 2025 | 58.93% |
| Sep 30, 2025 | 9.09% |
| Jun 30, 2025 | -4.25% |
| Mar 31, 2025 | -7.23% |
| Dec 31, 2024 | -2.71% |
| Sep 30, 2024 | 6.41% |
| Jun 30, 2024 | 1.43% |
| Mar 31, 2024 | -4.89% |
| Dec 31, 2023 | -3.55% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | 0.48% |
| Mar 31, 2023 | -3.71% |
| Dec 31, 2022 | -4.25% |
| Sep 30, 2022 | -0.08% |
| Jun 30, 2022 | -5.43% |
| Mar 31, 2022 | -6.46% |
| Dec 31, 2021 | 60.68% |
| Sep 30, 2021 | -10.26% |
| Jun 30, 2021 | -10.26% |
| Mar 31, 2021 | -9.20% |
| Dec 31, 2020 | -0.41% |
| Sep 30, 2020 | 58.88% |
| Jun 30, 2020 | -7.66% |
| Mar 31, 2020 | -6.54% |
| Dec 31, 2015 | -15.19% |
| Sep 30, 2015 | -15.97% |
| Jun 30, 2015 | 1.65% |